4 Results for "

anti-stroke

" in MedChemExpress (MCE) Product Catalog:
Products (4)

4 Results for "anti-stroke" in MCE Product Catalog:

Cat. No.: HY-19036
CAS No.: 104195-17-7
Target:  

Adrenergic Receptor

Research Areas:  

Neurological Disease

SDZ NVI 085 is a compound with CNS stimulatory effects, primarily through the α1-adrenoceptor subtype, with anti-cataplexy and anti-stroke activities. SDZ NVI 085 also has a significant alertness effect and can be used to study other types of excessive sleepiness .
loading...
    loading...
Cat. No.: HY-173449
CAS No.: 2833727-43-6
Target:  

TRP Channel

Research Areas:  

Neurological Disease

TRPM2-IN-1 (compound D10) is a potent TRPM2 inhibitor. TRPM2-IN-1 exhibits antistroke activity and significant neuroprotective effect. TRPM2-IN-1 can be used in the study of ischemic stroke .
loading...
    loading...
Cat. No.: HY-168096
CAS No.: 3067565-40-3
iNOs-IN-5 (Compound BN-4) is an inhibitor for iNOS with an IC50 of 0.1707 μM, and reduces NO levels in LPS (HT-D1056)-induced RAW264.7 cells. iNOs-IN-5 reduces the hypoxic injury stimulated ROS and lactate dehydrogenase expression, and exhibits anti-necrosis and anti-apoptosis efficacy. iNOs-IN-5 exhibits anti-cerebral ischemia and neuroprotective activities in SD rat models. iNOs-IN-5 is blood-brain barrier penetrable .
loading...
    loading...
Cat. No.: HY-157936
CAS No.: 3034593-10-4
Target:  

iGluR

Research Areas:  

Neurological Disease

GluN2B-NMDAR antagonist-2 (compound S-58) is a potent, selective and cross the blood-brain barrier NMDAR-GluN2B antagonist with an IC50 value of 74.01, nM. GluN2B-NMDAR antagonist-2 shows mild cytotoxicity. GluN2B-NMDAR antagonist-2 decreases the cerebral infarction rates and neurologic deficit scores. GluN2B-NMDAR antagonist-2 has the potential for the research of stroke .
loading...
    loading...